Gary Reedy

Johnson & Johnson, Worldwide Vice President, Biopharmaceutical Public Policy and Advocacy

Gary Reedy serves as Worldwide Vice President, Biopharmaceutical Public Policy and Advocacy with Johnson & Johnson, the world’s most comprehensive healthcare manufacturer. He is responsible for spearheading initiatives to influence global health policy for the company’s biopharmaceuticals business. Additionally, he has responsibility
for the Johnson & Johnson Political Action Committee and grassroots initiatives.

Gary began his career with Johnson & Johnson in 1993 as Group Director of Marketing for Janssen Pharmaceutica. He also was a founding member of Johnson & Johnson Health Care Systems, where he served as Vice President of Marketing before joining Ortho Biotech as Vice President of Sales & Marketing in 1996. Gary was appointed President of Ortho Biotech in May 2000, with commercial responsibility for both the United States and Canada. In this capacity, he led the organization to significant achievements in the therapeutic areas of cancer, immunology, chronic kidney disease, and acute and specialty care. Gary assumed his current corporate responsibility in April 2003 Gary has over 28 years of domestic and international experience in the pharmaceutical and biotechnology industry.

Prior to joining Johnson & Johnson, he held positions of increasing responsibility at SmithKline Beecham and Centocor. Gary is a member of the American Cancer Society Foundation Board of Trustees, serving as Chairman of the Development Committee, and as Foundation Trustee Liaison to the American Cancer Society National Board of Directors. He also sits on the Board of Directors of C-Change, is a charter member of the CEO Roundtable on Cancer and serves as Chairman of the CEO Cancer Gold StandardTM Task Force.